Sectors
SLN
Silence Therapeutics plc
13.14
2 x 7.92
2 x 14.22
bid
ask
-
0.28
2.05%
10:29 AM
timesize
| Ytd | 116.20% | |
| 1y | 173.28% |
13.14
day range
13.65
4.19
52 week range
17.58
| Open | 13.39 | Prev Close | 13.42 | Low | 13.14 | High | 13.65 | Mkt Cap | 817.33M |
| Vol | 59.30K | Avg Vol | 959.10K | EPS | -1.29 | P/E | N/A | Forward P/E | N/A |
| Beta | 1.39 | Short Ratio | 2.36 | Inst. Own | 62.77% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 11.42 | 200-d Avg | 7.49 | 1yr Est | 53.70 |
| Income Statement | |||
| Operating Expenses | 13.87M | ||
| Research and Development Expense | 9.15M | ||
| Selling, General and Administrative Expense | 4.72M | ||
| Operating Income | -13.86M | ||
| Income Tax Expense | 1000 | ||
| Net Income | -12.27M | ||
| Net Income Common Stock | -12.27M | ||
| Net Income Common Stock (USD) | -12.27M | ||
| Consolidated Income | -12.27M | ||
| Earnings per Basic Share | -0.27 | ||
| Earnings per Basic Share (USD) | -0.27 | ||
| Earnings per Diluted Share | -0.27 | ||
| Earning Before Interest & Taxes (EBIT) | -12.27M | ||
| Earning Before Interest & Taxes (USD) | -12.27M | ||
| Weighted Average Shares | 141.71M | ||
| Weighted Average Shares Diluted | 141.71M | ||
| Balance Sheet | |||
| Cash and Equivalents | 72.05M | ||
| Cash and Equivalents (USD) | 72.05M | ||
| Current Assets | 94.28M | ||
| Property, Plant & Equipment Net | 1.44M | ||
| Total Assets | 106.41M | ||
| Debt Current | 103.00K | ||
| Total Debt | 112.00K | ||
| Current Liabilities | 12.71M | ||
| Debt Non-Current | 9.00K | ||
| Total Liabilities | 67.94M | ||
| Accumulated Retained Earnings (Deficit) | 589.63M | ||
| Accumulated Other Comprehensive Income | 3.34M | ||
| Shareholders Equity | -38.47M | ||
| Shareholders Equity (USD) | -38.47M | ||
| Assets Non-Current | 12.13M | ||
| Total Debt (USD) | 112.00K | ||
| Deferred Revenue | 55.22M | ||
| Goodwill and Intangible Assets | 10.56M | ||
| Liabilities Non-Current | 55.23M | ||
| Trade and Non-Trade Payables | 12.61M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 108.00K | ||
| Net Cash Flow from Financing | 2.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 66.46M | ||
| Issuance (Purchase) of Equity Shares | 2.00K | ||
| Net Cash Flow from Investing | 64.94M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 64.94M | ||
| Net Cash Flow from Operations | 1.52M | ||
| Effect of Exchange Rate Changes on Cash | -63.00K | ||
| Share Based Compensation | 1.31M | ||